South Africa's biohacking community is small, well read and online, and it is where most of the country's peptide vocabulary comes from. The problem the community itself admits is that the reading list is a mix of real papers, influencer summaries and invented protocols, and separating them takes more time than most people have.
This page is the separation. It takes the compounds the community talks about most and states, for each, what the literature actually contains and how strong it is. It covers the mitochondrial, sleep, cognition and repair strands, and it points to primary sources. It contains no protocols and no dosing, because the site publishes none; the compounds are supplied for laboratory research only.
The mitochondrial strand is where the biohacking literature is strongest. SS-31 binds cardiolipin and has a 2025 regulatory approval in a rare mitochondrial disease; MOTS-c activates AMPK in mice and rises in human plasma after exercise; NAD+ sits under the sirtuin enzymes with mixed human precursor-trial results. The sleep strand has GHRH increasing slow-wave sleep in human sleep labs, Epitalon restoring melatonin rhythm in Russian cohorts, and DSIP's unresolved fifty-year history.
The cognition strand is dominated by Russian clinical pharmacology: Semax for BDNF induction and attention, Selank for anxiety without sedation, both registered medicines there. The repair strand is almost entirely rodent: BPC-157 and TB-500 in tendon, muscle and wound models. Across all four strands the pattern is the same: the mechanisms are real and well described; the human outcome data are thin or absent, and the community's protocols have no basis in any of it.
Cardiolipin-binding peptides and ATP
Exercise-responsive mitochondrial peptides
NAD+ precursor trials
Slow-wave sleep and melatonin rhythm
Russian clinical neuropeptides
Rodent repair models and their limits
Compounds that recur in this literature
Research context only — what each compound has been studied for in published work, not what it does for anyone. Independently tested by Janoshik Analytical.
SS-31
Research vial
The one biohacker-famous compound with a hard human endpoint: US accelerated approval in 2025 for muscle strength in Barth syndrome, on top of cardiolipin-binding and ATP-recovery work in injury models.
The mitochondrial-encoded peptide: AMPK activation and exercise capacity in mice, plasma levels that respond to exercise in humans. Mechanism solid, human outcomes unstudied.
ACTH(4-10) analogue and Russian registered medicine, studied for rapid BDNF induction, attention and stroke recovery. Human evidence from one tradition.
Self-experimenters order from everywhere, and The Courier Guy reaches everywhere from our Johannesburg hub: next business day in Gauteng, one to two days to the metros, two to three to small towns, tracked door to door. Weekday orders paid before noon dispatch the same afternoon in discreet packaging. A PUDO locker is selectable at checkout for anyone who would rather collect. Shipping is free over R2,500, and the certificate and verify links sit on every product page.
No, anywhere on the site. We describe the literature and supply compounds for laboratory research only.
Which biohacker peptide has the best evidence?
SS-31, with a regulatory approval. Semax and Selank have clinical studies in Russia. Most of the rest is mouse or cohort data, and we grade each product on a stated rubric.
Is BPC-157 as proven as the forums say?
No. Its findings come from rat and tissue models. There are almost no human trials.
How do I verify what I ordered?
Each product page links an independent Janoshik Analytical certificate stating identity and HPLC purity, and a verification page per compound.
Educational content — not medical advice. All products supplied for research purposes only. Not for human consumption.
Research Axes · 22 Goals
Shop by Goal
Start from what you want to change rather than from a compound name. Every goal below opens a full vertical — what the research points to, what we stock for it, and how to run it.